[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584572":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":28,"locations":34,"responsibleParty":52,"collaborators":24,"id":54,"slug":24,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":24,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":24,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":36,"whyStopped":24,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Medical University of Bialystok","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Rayone EMV","EXPERIMENTAL","Patient will receive the non-diffractive monofocal IOL during cataract surgery",[13],"Device: RayOne EMV",{"label":15,"type":10,"description":11,"interventionNames":16},"Vivinex Impress XY1-EM",[17],"Device: Vivinex Impress",[19,25],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DEVICE","RayOne EMV","non-diffractive monofocal IOL",[9],null,{"type":20,"name":26,"description":22,"armGroupLabels":27,"otherNames":24},"Vivinex Impress",[15],[29],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},"Joanna Konopinska, Associate proffesor","CONTACT","+48600471666","joannakonopinska@o2.pl",[35],{"facility":5,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Bialystok","Polska","15-866","Poland","PL",{"type":43,"coordinates":44},"Point",[45,46],23.16433,53.13333,{"lat":46,"lon":45},[49],{"name":50,"role":31,"phone":51,"phoneExt":24,"email":33},"Joanna Konopińska","600471666",{"type":53,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100584572",false,"NCT06891092","Vivinex Impress XY1-EM vs RayOne EMV","Comparison of Quality of Vision After Implantation of Monofocal Depth-enhanced Intraocular Lenses in Patients Undergoing Bilateral Cataract Surgery","Inclusion Criteria:\n\n* age-related bilateral cataract\n* age 21 or older\n* visual acuity \\> 0.05\n* axial length: 22.0 - 26.0 mm\n* normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant\n* written informed consent prior to surgery\n\nExclusion Criteria:\n\n* active ocular disease (e.g. chronic severe uveitis, proliferative diabetic retinopathy, chronic glaucoma not responsive to medication)\n* relevant other ophthalmic diseases such as pseudoexfoliation syndrome (PEX), intraoperative floppy iris syndrome (IFIS)\n* corneal decompensation or corneal endothelial cell insufficiency\n* previous ocular surgery or trauma\n* persons who are pregnant or nursing (pregnancy test will be taken in women of reproductive age)\n* corneal astigmatism \\> 1 dpt.\n* retinopathies","ALL","21 Years","80 Years",{"count":64,"type":65},100,"ESTIMATED","INTERVENTIONAL",[68],"NA","Comparison of the outcomes of bilateral implantation of extended depth of vision (EDOF) intraocular lenses (IOLs): the Rayone EMV and the Vivinex Impress XY1-EM in patients with cataract",[71],"Cataract",[22,73,74],"EDOF","cataract","2026-01-15",{"date":77,"type":78},"2026-01-20","ACTUAL",{"date":80,"type":78},"2026-01-01",{"date":82,"type":65},"2028-06-01",{"name":5,"class":6},1]